Medartis Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDRSF research report →
About the company
Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticated medical devices are engineered to support the surgical repair and stabilization of bone fractures, specifically targeting injuries in both upper and lower limbs, as well as intricate cranio-maxillofacial surgeries.
- CEO
- Matthias Schupp
- IPO
- 2020
- Employees
- 816
- HQ
- Basel, CH
Price Chart
- Market Cap
- $1.43B
- P/E
- 127.31
- P/S
- 3.94
- P/B
- 3.84
- EV/EBITDA
- 46.35
- Div Yield
- 0.00%
- Gross Margin
- 75.89%
- Op Margin
- 0.42%
- Net Margin
- 3.10%
- ROE
- 3.11%
- ROIC
- 0.16%
- Revenue
- $269.26M · 19.76%
- Net Income
- $8.35M · 136.65%
- EPS
- $0.67 · 157.69%
- Op Income
- $1.93M
- FCF YoY
- -55.47%
- 52W High
- $115.00
- 52W Low
- $66.68
- 50D MA
- $115.00
- 200D MA
- $102.93
- Beta
- 1.18
- Avg Volume
- 104.004
Get TickerSpark's AI analysis on MDRSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MDRSF coverage
Recent articles, reports, and earnings notes.
No research on MDRSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MDRSF report →Similar companies
Peers in the same neighborhood.